CALGARY, May 16 /CNW/ - SemBioSys Genetics Inc. (TSX:SBS), a
biotechnology company developing a portfolio of therapeutic proteins for
metabolic and cardiovascular diseases, today announced that its joint
development partner on the ImmunoSphere(TM) shrimp feed additive program, Aqua
Bounty Technologies Inc. (AIM: ABTX), has announced that it intends to scale
back marketing and registration efforts on its first generation shrimp feed
additive, IMS. SemBioSys is developing a second generation shrimp feed
additive product in safflower, ImmunoSphere(TM), that has the potential to
significantly reduce the manufacturing costs of the feed additive.
